Connect with us
European Gaming Congress 2024

Artificial Intelligence

DIAGNOS Announces Closing of Oversubscribed $2.1 Million Private Placement

Published

on

BROSSARD, Quebec, March 09, 2020 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces that it has completed the non-brokered private placement previously announced on February 24th, 2020. The Corporation issued a total of 11,901,995 common shares of the Corporation (each a “Share”) at a price of $0.18 per Share, for gross proceeds of $2,142,360.16 (the “Private Placement”). This represents an increase of 2,179,772 common shares and $392,360.16 over what was previously announced.
“We are very happy with the outcome of this oversubscribed financing. The support from significant shareholders and the participation from board members reinforce our confidence in the use of Artificial Intelligence for the early-detection of certain critical pathologies”, said Mr. André Larente, President of DIAGNOS. The proceeds from the Private Placement will be used mainly to fund sales and marketing as well as administrative expenses.Two directors of the Corporation have participated in the Private Placement. Mr. Georges Hébert indirectly acquired 277,778 Shares for a cash consideration of $50,000 and Mr. Francis Bellido acquired 555,556 Shares for a cash consideration of $100,000. Mr. Hébert now owns, directly and indirectly, 1,424,357 Shares of the Corporation representing 2.32% of the total issued Shares, on an undiluted basis. Assuming the exercise of stock warrants, Mr. Hébert would hold 1,524,357 Shares of the Corporation, representing 2.48% of the total issued Shares. Mr. Bellido now owns 555,556 Shares of the Corporation, representing 0.91% of the total issued Shares, on an undiluted and partially diluted basis.An insider of the Corporation, Mr. Tristram Coffin, acquired 783,334 Shares for a cash consideration of $141,000.12. Mr. Coffin now owns, directly and indirectly, 6,820,639 Shares of the Corporation representing 11.11% of the total issued Shares. Assuming the exercise of stock warrants, Mr. Coffin would hold 10,624,560 Shares of the Corporation, representing 16.84% of the total issued Shares. The Shares were acquired by Mr. Coffin for investment purposes only. Mr. Coffin has a long-term view of the investment in Shares of the Corporation and may acquire additional securities of the Corporation either on the open market or through private acquisitions or sell securities of the Corporation either on the open market or through private dispositions depending on market conditions, reformulation of plans and/or other relevant factors. A copy of Mr. Coffin’s early warning report will appear on the Corporation’s profile on SEDAR and can be obtained by contacting the Corporation at (450) 678-8882 extension 235. Mr Coffin’s participation in the Private Placement was unknown at the time the press release announcing the private placement was issued on February 24th, 2020.Mr. Hébert, Mr. Bellido and Mr. Coffin are considered “related parties” of the Corporation within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Private Placement is exempt from the valuation requirement and the minority approval requirement prescribed in MI 61-101 based on the fact that the fair market value of the related parties’ participation in the Private Placement does not exceed 25% of the Corporation’s market capitalization.In connection with the Private Placement, the Corporation paid a cash commission of $6,840 to one qualified person (“Finder”) and issued 38,000 broker warrants to the Finder. Each broker warrant entitles the holder to purchase one Share at an exercise price of $0.23 per Share for a period of 24 months ending March 9, 2022.All securities issued as part of the Private Placement are subject to a statutory four-month hold period ending July 10, 2020 and the Private Placement remains subject to receipt of all required approvals, including the approval of the TSX Venture Exchange, as well as the execution of formal documentation.All monies quoted in this press release shall be stated and paid in lawful money of Canada.About DIAGNOS
DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence (“AI”) tool CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care. CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients in real-time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration and the European Union.
Additional information is available at www.diagnos.com and www.sedar.com.This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publically update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact: Mr. André Larente, President
DIAGNOS Inc. Tel: 450-678-8882 ext. 224

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

DATAMARK Technologies Applauded by Frost & Sullivan for Advancing Location Determination Capabilities and Data Accuracy with Its Improved GIS and Indoor Mapping Solution

Published

on

datamark-technologies-applauded-by-frost-&-sullivan-for-advancing-location-determination-capabilities-and-data-accuracy-with-its-improved-gis-and-indoor-mapping-solution

DATAMARK INSIDE empowers first responders to visualize buildings in 3D, pinpoint the floor levels of 911 callers, and improve situational awareness for more precise and efficient emergency response planning and management.
SAN ANTONIO, Sept. 16, 2024 /PRNewswire/ — Frost & Sullivan researched the indoor mapping industry and, based on its analysis, recognizes DATAMARK Technologies with the 2024 North American New Product Innovation Award. The company combines the expertise of Michael Baker’s public safety and GIS data management capabilities with Digital Data Technologies, Inc.’s top-tier Next Generation 911 location services. The unified brand offers an integrated solution that enhances call routing accuracy, provides seamless discrepancy resolution, and ensures high location fidelity for call takers. By leveraging advanced technologies such as indoor mapping, light detection and ranging (LiDAR), and digital twin technology, the company positions itself to serve the government technology and public safety market with unparalleled data accuracy and interoperability. INSIDE™, DATAMARK’s cloud-native indoor mapping solution, revolutionizes building safety by integrating precise indoor data with tools for effective exit planning, emergency asset access, and incident response.

DATAMARK’s advanced indoor mapping platform allows users to visually manage, update, and collaborate on highly accurate indoor information, enhancing situational awareness and operational efficiency. INSIDE transforms indoor maps into actionable intelligence by creating a common operating picture for public safety stakeholders and facility managers. It empowers first responders to plan efficient entry and exit routes, swiftly access equipment, and precisely locate incidents. With 360-degree imagery and closed-circuit television integration features, INSIDE provides a detailed virtual view of every room, aiding faster wayfinding and coordination. The platform supports collaboration through a role-based interface, permitting multiple users to access and utilize indoor mapping data from smartphones, tablets, or computers. INSIDE’s real-time integration with security camera footage enables public safety personnel to assess incidents before arriving on-site, improving response effectiveness and spatial awareness.
Brent Iadarola, vice president at Frost & Sullivan, observed, “DATAMARK’s innovative approach to real-time GIS data management and integration significantly enhance decision-making and response times in public safety operations. The company sets a new standard for data accuracy and interoperability in the indoor mapping market by leveraging advanced technologies and ensuring comprehensive, scalable, and secure solutions.”
DATAMARK’s INSIDE platform integrates high-quality data with industry-standard GIS systems for seamless connectivity with public safety systems. It addresses the limitations of outdated, paper-based building plans by offering up-to-date digital data accessible to all authorized personnel. The critical information flows seamlessly to those who need it, optimizing asset management, enhancing situational awareness, and enabling efficient emergency responses when every second counts. DATAMARK’s primary differentiator is the ability to manage access to sensitive data securely. Its system permits credential-based access, ensuring only authorized personnel can view and update data. This controlled access is vital when dealing with critical infrastructure and sensitive information, providing security and flexibility in data management. The company’s comprehensive and scalable solutions, its cost-effective and efficient skeletal data collection and management approach, and its emphasis on the importance of sustainable data management also set it apart in the industry.
“DATAMARK’s INSIDE™ allows real-time updates to indoor mapping data, ensuring all stakeholders access the most current and accurate information. This feature enhances operational efficiency by dynamically updating floor plans and critical data across all integrated systems, including computer-aided dispatch and emergency management platforms. By promptly addressing user needs and integrating their suggestions, DATAMARK continually refines its solutions to better serve its clients’ evolving requirements,” added Ojaswi Rana, best practices research analyst at Frost & Sullivan.
Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.
Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.
Contact:
Camila TinajeroP: +54911 6713 2748E: [email protected]
Logo – https://mma.prnewswire.com/media/2505170/DATAMARK_Technologies__Award.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/datamark-technologies-applauded-by-frost–sullivan-for-advancing-location-determination-capabilities-and-data-accuracy-with-its-improved-gis-and-indoor-mapping-solution-302247953.html

Continue Reading

Artificial Intelligence

Lab Automation Market to Reach $11.31 Billion by 2031, Driven by Rising Pharmaceutical & Biotech R&D Expenditures and Increasing Demand for Automated Laboratories and Instruments – Report by Meticulous Research®

Published

on

lab-automation-market-to-reach-$11.31-billion-by-2031,-driven-by-rising-pharmaceutical-&-biotech-r&d-expenditures-and-increasing-demand-for-automated-laboratories-and-instruments-–-report-by-meticulous-research

REDDING, Calif., Sept. 16, 2024 /PRNewswire/ — According to a new market research report titled, ‘Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics),End User—Global Forecast to 2031.

The lab automation market is projected to reach $11.31 billion by 2031, at a CAGR of 7.3% from 2024 to 2031.
Download FREE PDF Brochure Of Lab Automation Market – https://www.meticulousresearch.com/pressrelease/967/lab-automation-market-2031
Rising pharmaceutical and biotech R&D expenditures, the increasing demand for automated laboratories and instruments, the high prevalence of chronic and infectious diseases, and initiatives supporting life sciences R&D are driving the growth of the lab automation market. However, the high costs of advanced lab automation equipment and funding & infrastructure limitations in developing countries are factors restraining the growth of this market.
Furthermore, growth in genomics & proteomics research, the increasing focus on food safety & quality, rising awareness & growing adoption of personalized medicines, and emerging economies are expected to generate growth opportunities for the players operating in the lab automation market. However, equipment maintenance & repair and data security & privacy concerns are major challenges impacting market growth.
Get Insightful Data On Regions, Market Segments, Customer Landscape, And Top Companies (Charts, Tables, Figures And More) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Automated Laboratories: Effective Management of Clinical Workflows
Lab automation is being widely adopted in clinical laboratories to increase accuracy and efficiency and reduce costs and errors. In the field of medicine, a diagnostic error can incur very high costs. Hence, automating clinical laboratories can significantly reduce human errors and associated costs.
Automating clinical laboratories can have a positive impact on patient outcomes. Quick and reliable diagnostic results allow medical professionals to initiate appropriate treatments, improving the chances of patient survival. Additionally, limited resources, long waiting times for diagnostic results, and the shortage of skilled laboratory staff can lead to poor patient outcomes. The implementation of lab automation in clinical laboratories helps mitigate these issues and provides quick and reliable results, improving patient outcomes.
In the U.S., an estimated 10–20% of diagnoses are inaccurate and result in 40,000–80,000 deaths each year. Automation improves the ordering, testing, and reporting of diagnostic tests and ensures higher throughput, increased productivity, efficient use of reagents & materials, and standardization, decreasing errors and improving turnaround times.
Browse In-depth Report Now – https://www.meticulousresearch.com/product/lab-automation-market-1221
The players operating in this market are focused on launching new automated diagnostic instruments. For instance:
In May 2024, Abbott Laboratories (U.S.) launched its GLP Systems Track in India to support the high-volume needs of laboratories.In September 2023, Yourgene Health plc (U.K.) launched the Yourgene MagBench Automated DNA Extraction Instrument and Kit for Noninvasive Prenatal Testing (NIPT) workflows.In June 2023, Becton, Dickinson and Company (U.S.) launched its BD FACSDuet Premium Sample Preparation System for cellular diagnostic applications.In January 2023, QIAGEN N.V. (Netherlands) launched the EZ2 Connect MDx Platform for automated sample processing in diagnostic labs.In May 2022, Becton, Dickinson and Company (U.S.) launched BD COR MX, a fully automated, high-throughput infectious disease molecular diagnostics platform.Lab Automation Market Analysis: Key Segmental Findings
By Product: In 2024, the systems segment is expected to account for the major share of 71.5% of the lab automation market. However, the software segment is expected to grow at the fastest CAGR of 7.4% during the forecast period of 2024–2031.By Application: In 2024, the drug discovery segment is expected to account for the largest share of the market. However, the clinical diagnostics segment is expected to grow at the fastest CAGR during the forecast period of 2024–2031.By End User: In 2024, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of 41.0% of the global market.Explore the Key Market Segments Driving Growth (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Geographic Analysis:
North America Dominates the Global Market
North America is expected to account for the largest share of 40.8% of the lab automation market. In terms of value, in 2024, the U.S. is expected to account for the major share of 92% of the lab automation market in North America. Pharmaceutical companies in the U.S. are at the forefront of adopting cutting-edge technologies, with a strong emphasis on the implementation of lab automation systems to enhance operational efficiency and gain a competitive edge in the pharmaceutical sector. The adoption of lab automation technologies is driven by several factors, including the surging need for high-throughput analysis, increasing investments in research and development, laboratories’ growing need for increased efficiency, precision, and productivity, and the increasing focus on genomics research and genetic testing. These dynamics are boosting the adoption of lab automation across the country. The U.S. has low market barriers for developing and commercializing pharmaceuticals due to the supportive domestic environment. With the availability of government funding for research activities, robust capital markets, and strong academic research in the country, the U.S. is the world’s largest scientific research base, attracting most global venture capital investments in the biotechnology industry.
Asia-Pacific to Witness Rapid Growth
Asia-Pacific is expected to record the fastest growth over the forecast period, with the regional market reaching $2.74 billion by 2031. The high growth of this regional market is driven by the expanding pharmaceutical & biotechnology industries, rapidly improving healthcare infrastructure, growth in pharmaceutical research, and increasing government funding in APAC. The Asia-Pacific region has become one of the most attractive markets for healthcare & life sciences companies worldwide, primarily due to changing demographics and accelerated economic growth in the region. Countries such as China, India, South Korea, and Indonesia are expanding their healthcare infrastructure, driving the demand for laboratory automation.
Have specific research needs? Request a customized research report – https://www.meticulousresearch.com/request-customization/cp_id=1221
In 2024, China is expected to account for the largest share of the lab automation market in Asia-Pacific. The country’s large market share is mainly attributed to government initiatives focusing on research and development, increasing R&D expenditures of pharmaceutical and biopharmaceutical companies, favorable regulatory policies, the rising prevalence of infectious & chronic diseases, the rising geriatric population, and the increased demand for lab automation among clinical laboratories due to increased disease prevalence.
Germany Continues to Dominate the Lab Automation Market in Europe
In 2024, Germany is expected to account for the largest share of the lab automation market in Europe. Factors such as increasing government investments in the pharmaceutical industry, growing biotech & pharmaceutical R&D expenditures, rising healthcare spending, increasing sample volumes in laboratories due to the rising incidence of chronic and infectious diseases, the increased demand for precision medicines, and the rising focus on genomics research contribute to the country’s largest market share. Germany has a favorable environment for developing and producing research-intensive, high-grade products. According to German Trade & Invest, in 2021, the pharmaceutical industry in Germany invested over $9.1 billion (€7.7 billion) in research and development. Additionally, the government and funding organizations have pledged to substantially increase public & private R&D spending and researchers by 2030 as part of the country’s Sustainable Development Goals (SDG). Thus, increasing government funding for research, the wide availability of technologically advanced laboratory informatics solutions, and laboratories’ need to reduce errors, and associated costs are expected to drive the growth of the lab automation market in Germany.
Need Insights on Regional Data? Check Out Our Detailed Analysis (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Lab Automation Market: Competition Analysis
This report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted over the past 3–4 years. Major companies in the lab automation market have implemented various strategies to expand their product offerings and global footprints and augment their market shares. The key strategies followed by most companies in the lab automation market include product launches, product enhancements, approvals, partnerships, collaborations, agreements, acquisitions, and expansions. The key players operating in the lab automation market include Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Learn About the Top Companies Influencing Market Dynamics (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Lab Automation Industry Overview: Latest Developments from Key Industry Players
In July 2024, INPECO SA (Switzerland) launched FlexLab X, a next-generation total lab automation system (TLA), at the Annual Scientific Meeting of the Association for Diagnostics & Laboratory Medicine (ADLM 2024). This system can combine analyzers from different vendors, enable space-saving layouts, offers a sleek graphical user interface, and streamlines workflows.In February 2024, Carbon, Inc. (U.S.) launched its Automatic Operation (AO) suite of solutions designed to meet the needs of dental labs, setting new standards in lab automation.In September 2023, Bio-Rad Laboratories, Inc. launched the PTC Tempo 48/48 and PTC Tempo 384 thermal cyclers that are designed to aid PCR applications such as sequencing, cloning, and genotyping.In August 2023, F. Hoffmann-La Roche Ltd launched the Cobas Connection Modules (CCM) sample conveyor systems to enable flexibility in laboratory designs.In July 2023, Agilent Technologies, Inc. launched the BioTek Gen6 Software, which is used for all BioTek detection instruments. This software also provides an intuitive user interface that offers complete control of BioTek microplate readers for absorbance, fluorescence, and luminescence measurements for endpoint and kinetic assays.In July 2023, Thermo Fisher Scientific, Inc. launched the Diomni Enterprise Software, which provides a digital platform to support testing workflows in order to accommodate rapidly evolving needs.In July 2023, Bio-Rad Laboratories launched the IH-500TM NEXT System, a fully automated system for use with Bio-Rad’s ID Cards for routine testing and specialized testing such as newborn screening.In February 2023, Revvity, Inc. launched the EnVision Nexus Multimode Microplate Reader, which provides high-throughput screening and accelerates drug discovery results.In February 2023, Beckman Coulter Life Sciences collaborated with Sciex (U.S.) to provide comprehensive workflows for high-throughput screening HT-ADME and synthetic biology studies. The Echo MS System, which is based on Sciex’s Acoustic Ejection Mass Spectrometry technology, is now compatible with Beckman’s Echo Liquid Handlers.In February 2023, Tecan Group Ltd. collaborated with Element Biosciences, Inc. (U.S.) to offer a true benchtop NGS workflow with the MagicPrep NGS and AVITI System. This collaboration was aimed at enabling the direct conversion of NGS libraries without affecting sample quality.In June 2022, Beckman Coulter Life Sciences launched the Biomek NGeniuS liquid handling system to automate the labor-intensive process of manual library construction and reagent transfers. The system also eliminates loading errors.In April 2022, Revvity, Inc. collaborated with Scitara Corporation (U.S.) to integrate PerkinElmer’s Signals Research Suite informatics platform and Scitara’s iPaaS universal connectivity solution to facilitate fully connected laboratories along with standard data integrity, data mobility, system flexibility, and user reconfigurability.The report provides a competitive dashboard summarizing the market positioning of the 20 profiled market players in four quadrants, namely Industry Leaders, Differentiators, Emerging Companies, and Vanguards. These companies are positioned based on various parameters, including revenue, depth of offerings, brand equity, geographic presence, innovation, and organic & inorganic growth strategies. Thermo Fisher Scientific, Inc. (U.S), Danaher Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Hamilton Company (U.S.), Abbott Laboratories (U.S.), and Siemens Healthineers AG (Germany) are positioned in the industry leaders quadrant.
IMMEDIATE DELIVERY AVAILABLE | BUY THIS RESEARCH REPORT (Insights, Charts, Tables, Figures and More)- https://www.meticulousresearch.com/Checkout/13937383
Scope of the Report:
Lab Automation Market Assessment–by Product
SystemsAutomated Liquid Handling SystemsAutomated Nucleic Acid Purification SystemsAutomated ELISA SystemsAutomated Microplate ReadersAutomated Storage & Retrieval SystemsOther Lab Automation SystemsSoftwareLaboratory Information Management Systems (LIMS)Electronic Lab Notebook (ELN)Workstation/Equipment Automation SoftwareScientific Data Management Systems (SDMS)Lab Automation Market Assessment–by Application
Drug DiscoveryClinical DiagnosticsGenomics & Proteomics ResearchOther Applications(Note: Other applications include bioprocessing in biotechnology, cell analysis, basic research, forensic analysis, and quality control in the F&B industry.)
Lab Automation Market Assessment–by End User
Pharmaceutical & Biotechnology CompaniesHospitals & Diagnostic LaboratoriesAcademic & Research InstitutesOther End Users(Note: Other end users include the food & agriculture industries, forensic laboratories, blood banks, and environmental & quality testing laboratories.)
Lab Automation Market Assessment–by Geography
North AmericaU.S.CanadaEuropeGermanyU.K.FranceItalySpainRest of Europe (RoE)Asia-Pacific (APAC)ChinaJapanIndiaRest of APAC (RoAPAC)Latin AmericaMiddle East & AfricaBrowse More Related Reports:
Lab Automation Market is projected to hit $11.31 billion by 2031, growing at CAGR of 7.3% from 2024. Discover trends and growth factors driving this sector. – https://www.meticulousresearch.com/product/lab-automation-market-1221
Clinical Lab Automation Market is expected to reach $4.01 billion by 2031, at a CAGR of 7.8% from 2024 to 2031. – https://www.meticulousresearch.com/product/clinical-lab-automation-market-5762
Electronic Lab Notebook Market is expected to grow at a CAGR of 7.1% to reach $787.7 million by 2029. – https://www.meticulousresearch.com/product/electronic-lab-notebook-eln-market-4341
NGS Automation Market is expected to grow at a CAGR of 13.4% from 2022–2029 to reach $1.33 billion by 2029. – https://www.meticulousresearch.com/product/ngs-automation-market-5271
Explore future of  Industrial Automation Software Market, projected to hit $59.5 billion by 2029.  – https://www.meticulousresearch.com/product/industrial-automation-software-market-5279
Pharmaceutical Automation Market, valued at $11.16 Bn in 2023, is projected to reach $25.11 Bn by 2031, growing at a 10.8% CAGR from $12.21 Bn in 2024. – https://www.meticulousresearch.com/product/pharmaceutical-automation-market-5280
Lab-grown Meat Market is projected to reach $1.99 billion by 2035, at a CAGR of 21.4% during  forecast period of 2025–2035. – https://www.meticulousresearch.com/product/lab-grown-meat-market-5293
North America Electronic Lab Notebooks Market is projected to reach $372.7 million by 2030, at a CAGR of 6.8% from 2024 to 2030. – https://www.meticulousresearch.com/product/north-america-electronic-lab-notebook-market-5604
Europe Electronic Lab Notebook (ELN) Market is projected to reach $264.3 million by 2030, at a CAGR of 7% from 2024 to 2030. – https://www.meticulousresearch.com/product/europe-electronic-lab-notebook-market-5683
Pharmacy Automation Market is expected to reach $7.87 billion by 2030, at a CAGR of 7.6% during forecast period 2024–2030. – https://www.meticulousresearch.com/product/pharmacy-automation-market-5700
Life science equipment market is projected to reach $97.96 billion by 2031, at a CAGR of 6.3% from 2024 to 2031 – https://www.meticulousresearch.com/product/life-science-equipment-market-3937
Europe NGS automation Market to be worth $380.4 million by 2030, growing at a 13.4% CAGR from 2024 to 2030. – https://www.meticulousresearch.com/product/europe-ngs-automation-market-5644
North America NGS Automation Market is expected to reach $776.1 million by 2030, at a CAGR of 14% during  forecast period 2024–2030 – https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736
Asia-Pacific NGS Automation Market is expected to reach $371 million by 2031 at a CAGR of 16.3% from 2024 to 2031 – https://www.meticulousresearch.com/product/asia-pacific-ngs-automation-market-5790
Lab Automation Market Research Summary
Particular
Details
Page No
244
Format
PDF
Forecast Period
2024-2031
Base Year
2023
CAGR
7.30 %
Market Size (Value)
$11.31 billion
Market Size (Volume)
NA
Countries Covered
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa.
Key Companies
Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), Hamilton Company (U.S.)
Click here to: Get Free Sample Pages of this Report
Hot Industry Reports: Emerging Trends and Market Forecasts
Veterinary Practice Management Software Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/veterinary-practice-management-software-market-1432
Asia Pacific Orthodontics Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/asia-pacific-orthodontics-market-4978
Feed Software Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/feed-software-market-2639
Point-of-care Diagnostics Market Size & Trends Analysis 2030 – https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871
Soluble Dietary Fibers Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/soluble-dietary-fibers-market-3953
Genomics Market: Size, Trends & Global Forecast to 2031 – https://www.meticulousresearch.com/product/genomics-market-1262
Healthcare Gamification Market Size, Share, & Growth 2030 – https://www.meticulousresearch.com/product/healthcare-gamification-market-2592
3D Cell Culture Market Size & Growth Insights 2024-2030 – https://www.meticulousresearch.com/product/3d-cell-culture-market-1246
South East Asia Collagen Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/south-east-asia-collagen-market-3634
Next Generation Sequencing Informatics (NGS) Market Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/ngs-informatics-market-3483
Recombinant Coagulation Factors Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/recombinant-coagulation-factors-market-1254
Crop Protection Chemicals Market Size, Share, Report, & Trends 2031 – https://www.meticulousresearch.com/product/crop-protection-chemicals-market-2584
Integrated Pest Management (IPM) Pheromones Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/integrated-pest-management-pheromones-market-5211
Sports Medicine Market: Size, Share, Forecast & Trends – https://www.meticulousresearch.com/product/sports-medicine-market-1215
MRI Infrastructure Capacity Assessment by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/mri-infrastructure-capacity-assessment-1217
Digital X-ray Systems Market Size, Share, Forecast, & Trends – https://www.meticulousresearch.com/product/digital-x-ray-systems-market-1183
Sports Technology Market Size, Trends & Forecast to 2030 – https://www.meticulousresearch.com/product/sports-technology-market-5584
Home Healthcare Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/home-healthcare-market-1280
Next Generation Sequencing Market Size, Share & Trends 2023-2030 – https://www.meticulousresearch.com/product/next-generation-sequencing-market-5040
Cloud Analytics Market Insights: Size, Share & Trends – https://www.meticulousresearch.com/product/cloud-analytics-market-5208
Home Medical Equipment Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/home-medical-equipment-market-1284
IoT in Healthcare Market Size, Share, & Trends 2031 – https://www.meticulousresearch.com/product/iot-in-healthcare-market-4945
Surgical Sutures Market by Size, Share, & Trends 2030 – https://www.meticulousresearch.com/product/surgical-sutures-market-4947
Lab Automation Market: Share, Trends & Forecast Analysis – https://www.meticulousresearch.com/product/lab-automation-market-1221
Asia Pacific EV Battery Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/asia-pacific-ev-battery-market-5217
Medical Imaging Market: Products, Applications, & Forecasts – https://www.meticulousresearch.com/product/medical-imaging-market-4950
Medical Ceramics Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/medical-ceramics-market-5538
Pharmaceutical Packaging Market Size, & Trends 2031 – https://www.meticulousresearch.com/product/pharmaceutical-packaging-market-5298
Ultrasound Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/ultrasound-market-4972
Tissue Diagnostics Market Insights: Size, Trends & Forecast – https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971
Contact:Mr. Khushal BombeMeticulous Market Research Inc.1267 Willis St, Ste 200 Redding,California, 96001, U.S.USA: +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- [email protected] Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Meticulousblog.org | Top Market Research Reports Blog – https://meticulousblog.org/Content Source: https://www.meticulousresearch.com/pressrelease/967/lab-automation-market
Photo: https://mma.prnewswire.com/media/2506511/Lab_Automation_Market.jpgLogo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/lab-automation-market-to-reach-11-31-billion-by-2031–driven-by-rising-pharmaceutical–biotech-rd-expenditures-and-increasing-demand-for-automated-laboratories-and-instruments—report-by-meticulous-research-302249256.html

Continue Reading

Artificial Intelligence

Agoric and Noble Partner to Deliver Fast USDC For Rapid Transfers Powered by Orchestration

Published

on

agoric-and-noble-partner-to-deliver-fast-usdc-for-rapid-transfers-powered-by-orchestration

ORINDA, Calif., Sept. 16, 2024 /PRNewswire/ — Agoric, a layer 1 blockchain designed for multi-chain orchestration, announced today a strategic partnership with Noble, the premier RWA issuance chain in the modular ecosystem, to build Fast USDC. This new solution will dramatically reduce wait times when transferring USDC from Ethereum and other EVM-compatible chains into the Cosmos ecosystem when using the Noble Express application. By streamlining the process, Fast USDC enhances the user experience and accelerates onboarding for Web3 services.

Stablecoins, valued today at over $100 billion, has proven recently to be a Web3 killer app, and Circle has taken the lead in driving inter-blockchain transfers with their Cross-Chain Transfer Protocol (CCTP) to help reduce friction, increase safety, and reduce costs when sending USDC from one blockchain to another. Agoric relies on this transfer protocol, but builds on that with a Fast USDC solution.
One of the persistent challenges in the Web3 economy has been the slow and complex process of transferring assets across different blockchain networks, creating barriers to user adoption and growth. Traditional cross-chain transfers, particularly involving USDC, can take upwards of 20 minutes, a delay driven by finality challenges on some blockchains that can degrade the experience for users accustomed to instant transactions.
Fast USDC: A Faster, Smoother Experience
Fast USDC addresses this challenge head-on by leveraging Noble’s minimalist architecture to enable cross-chain transfers from Ethereum and other EVM chains to Cosmos chains. Fast USDC utilizes an on-chain Agoric Orchestration contract which interacts with accounts on the Noble chain, facilitating a verifiable flow of funds. Through an innovative settlement model, users can receive USDC almost instantly, reducing transfer times from as much as 20 minutes down to less than 2 minutes.
Fast USDC is more than just a faster way to move funds—it is a critical step toward achieving chain abstraction. For developers, Fast USDC is a building block that can be embedded into Agoric Orchestration contracts that provide deeper specific user experiences across many chains with only a single user signature. This will unlock experiences that bring in far greater adoption of blockchain-based applications.
Key Features and Benefits:
Rapid Transfers and Orchestration: The solution reduces transfer times of USDC from EVM chains to Cosmos by 10x, bringing usability of Web3 solutions closer to the seamless flows of any mainstream application.Enhanced User Experience: With FastUSDC, users will be able to onboard their USDC into Cosmos chains and apps while they wait, improving their experience and enhancing user retention.Decentralized and On-Chain: Thanks to the programmability of Agoric Orchestration, Fast USDC assets are managed entirely on-chain to ensure transparency, a necessity for mainstream adoption.”Fast USDC is a key use case showcasing the unmatched cross-chain programmability of Agoric Orchestration. It demonstrates how orchestration can solve critical challenges for Web3 users and applications,” said Dean Tribble, CEO at Agoric Systems. “Our collaboration with Noble is a testament to our shared vision of simplifying blockchain technology to drive mainstream adoption.”
“Fast USDC is an exciting use case that leverages Noble’s unique architecture and we are thrilled to partner with the Agoric team on this important initiative,” said Jelena Djuric, CEO at Noble.
Availability
Fast USDC will soon be available across major blockchain platforms, providing developers and users with a powerful tool to enhance the speed and usability of their decentralized applications. This partnership marks a significant step forward in the mission to make Web3 experiences accessible and user-friendly.
For more information about Fast USDC and how it fits into Agoric’s orchestration solutions and Noble’s RWA framework, please visit agoric.com and noble.xyz.
Dean Tribble, CEO of Agoric Systems, and Jelena Djuric, CEO of Noble, are available for interview
About Agoric
Agoric is a layer 1 blockchain for orchestration. In the fragmented blockchain landscape, Agoric brings orchestration to Web3 to solve the chain abstraction challenge and foster composability and true interoperability that unlock a new era of universal liquidity. Agoric is the brainchild of renowned computer scientists, Dean Tribble and Mark Miller. Their groundbreaking work in secure computing and distributed systems laid the foundation for Agoric’s innovative technology.
About Noble
Noble is the premier asset issuance chain in the modular ecosystem. Noble solves a variety of critical pain points around native issuance, including security, liquidity, compliance, standardization and neutrality. Noble’s long-term vision is to be a UX unlock for all stablecoin and RWA issuers.
Press Contact: Alissa Karpick, Wachsman, E: [email protected]
 

View original content:https://www.prnewswire.co.uk/news-releases/agoric-and-noble-partner-to-deliver-fast-usdc-for-rapid-transfers-powered-by-orchestration-302249013.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending